Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M24,588Revenue $M7,380Net Margin (%)-3.4Altman Z-Score1.1
Enterprise Value $M28,614EPS $-0.1Operating Margin %-6.4Piotroski F-Score6
P/E(ttm)--Beneish M-Score-2.9Pre-tax Margin (%)-9.6Higher ROA y-yN
Price/Book3.710-y EBITDA Growth Rate %--Quick Ratio0.9Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %--Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow39.1y-y EBITDA Growth Rate %-105.1ROA % (ttm)-1.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-3.9Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M1,341ROIC % (ttm)6.3Gross Margin Increase y-yY

Gurus Latest Trades with BSX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BSXMario Gabelli 2015-03-31 Reduce-0.02%$13.22 - $18.07
($15.8)
$ 18.3416%Reduce 20.16%1,317,796
BSXDodge & Cox 2015-03-31 Reduce-0.01%$13.22 - $18.07
($15.8)
$ 18.3416%Reduce 38.43%729,460
BSXDodge & Cox 2014-12-31 Reduce-0.49%$11.37 - $13.68
($12.78)
$ 18.3444%Reduce 97.34%1,184,730
BSXVanguard Health Care Fund 2014-12-31 Add0.27%$11.37 - $13.68
($12.78)
$ 18.3444%Add 16.36%59,624,800
BSXLeon Cooperman 2014-09-30 Sold Out -1.1%$11.92 - $13.29
($12.59)
$ 18.3446%Sold Out0
BSXVanguard Health Care Fund 2014-09-30 Add0.25%$11.92 - $13.29
($12.59)
$ 18.3446%Add 19.88%51,242,050
BSXLeon Cooperman 2014-06-30 Reduce-0.35%$12.58 - $13.77
($13.01)
$ 18.3441%Reduce 23.25%6,549,479
BSXVanguard Health Care Fund 2014-06-30 Add0.2%$12.58 - $13.77
($13.01)
$ 18.3441%Add 16.19%42,743,200
BSXLeon Cooperman 2013-12-31 Reduce-0.88%$11.18 - $12.38
($11.81)
$ 18.3455%Reduce 36.64%8,533,099
BSXMichael Price 2013-12-31 Add0.47%$11.18 - $12.38
($11.81)
$ 18.3455%Add 17.65%2,000,000
BSXDodge & Cox 2013-12-31 Reduce-0.18%$11.18 - $12.38
($11.81)
$ 18.3455%Reduce 22.34%45,938,468
BSXVanguard Health Care Fund 2013-12-31 Reduce-0.06%$11.18 - $12.38
($11.82)
$ 18.3455%Reduce 3.80%36,787,000
BSXJoel Greenblatt 2013-12-31 Sold Out -0.01%$11.18 - $12.38
($11.81)
$ 18.3455%Sold Out0
BSXMario Gabelli 2013-12-31 Reduce$11.18 - $12.38
($11.82)
$ 18.3455%Reduce 1.50%2,201,305
BSXLeon Cooperman 2013-09-30 Reduce-0.42%$9.15 - $11.99
($10.83)
$ 18.3469%Reduce 18.19%13,467,416
BSXDodge & Cox 2013-09-30 Reduce-0.25%$9.15 - $11.99
($10.83)
$ 18.3469%Reduce 27.68%59,157,107
BSXVanguard Health Care Fund 2013-09-30 Reduce-0.24%$9.15 - $11.99
($10.83)
$ 18.3469%Reduce 15.74%38,240,700
BSXCharles Brandes 2013-09-30 Sold Out -0.07%$9.15 - $11.99
($10.83)
$ 18.3469%Sold Out0
BSXJoel Greenblatt 2013-09-30 Reduce-0.02%$9.15 - $11.99
($10.83)
$ 18.3469%Reduce 69.22%18,744
BSXCharles Brandes 2013-06-30 Reduce-1.54%$7.09 - $9.64
($8.48)
$ 18.34116%Reduce 96.31%624,088
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BSX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BSX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
JOHNSON KRISTINA MDirector 2015-05-18Sell16,301$18.1-0.61view
MARIO ERNESTDirector 2015-05-18Sell50,000$18.09-0.55view
Sununu John EDirector 2015-05-14Sell10,000$17.870.67view
Sorenson John BradleySVP, Manuf & Sup Chn 2015-05-11Sell8,735$17.492.86view
Ballinger Kevin J.SVP & Pres, Interven Cardio 2015-05-04Sell67,964$17.910.45view
Phalen Michael P.EVP & President, MedSurg 2015-03-20Sell46,085$17.940.28view
Pierce David ASVP and President, Endoscopy 2015-03-20Sell18,050$18-0.06view
Phalen Michael P.EVP & President, MedSurg 2015-03-16Sell30,022$17.184.71view
Sorenson John BradleySVP, Manuf & Sup Chn 2015-03-13Sell3,830$16.846.83view
Pierce David ASVP and President, Endoscopy 2015-03-09Sell2,561$16.548.77view

Press Releases about BSX :

    Quarterly/Annual Reports about BSX:

    News about BSX:

    Articles On GuruFocus.com
    Endo Pharmaceuticals Posts A Solid Q1 Earnings Report May 12 2015 
    Vanguard Adds to Four of Its Largest Stakes May 04 2015 
    Diamond Hill Select Fund Q4 2014 Commentary Mar 17 2015 
    Boston Scientific Finally Wins Positive Nod For Watchman Heart Device In U.S. Leaving Investors Impr Mar 17 2015 
    Endo International Shares Upbeat After Positive Q4 Earnings Report Mar 03 2015 
    Enphase Energy (ENPH) Record-Breaking Growth, Boston Scientific (BSX) and Johnson & Johnson (JNJ) En Feb 18 2015 
    A Robust Q4 Earnings Report From Boston Scientific Feb 10 2015 
    Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
    Boston Scientific Lost the First Place in Innovation Dec 11 2014 
    Diamond Hill Capital Comments on Boston Scientific Corp Oct 17 2014 

    More From Other Websites
    Top Healthcare, Medical Equipment Stocks of 2015 May 27 2015
    Boston Scientific Names Prof. John Mark Morgan as Senior Medical Director, Rhythm Management May 27 2015
    Boston Scientific To Participate In The Goldman Sachs 36th Annual Global Healthcare Conference May 26 2015
    Boston Scientific To Participate In The Goldman Sachs 36th Annual Global Healthcare Conference May 26 2015
    Boston Scientific Lotus Valve System: Key to Clinical Efficacy - Analyst Blog May 25 2015
    Considering the Investment Impact of Baby Boomers’ Retirement May 25 2015
    Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low... May 20 2015
    Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low... May 20 2015
    New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable... May 19 2015
    Taking the Pulse of Cardiac-Rhythm Management May 18 2015
    Intel Corporation (INTC), Hess Corp. (HES), Boston Scientific Corporation (BSX): Billionaire Michael... May 18 2015
    The 10 stocks likely to drop this summer: Goldman May 15 2015
    BOSTON SCIENTIFIC CORP Financials May 13 2015
    BOSTON SCIENTIFIC CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD... May 12 2015
    Boston Scientific Completes $1.85 Billion Senior Notes Offering May 12 2015
    Boston Scientific Completes $1.85 Billion Senior Notes Offering May 12 2015
    Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2015 May 11 2015
    Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2015 May 11 2015
    10-Q for Boston Scientific Corp. May 08 2015
    BOSTON SCIENTIFIC CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 08 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK